scholarly article | Q13442814 |
P2093 | author name string | Lisa D Pedicone | |
Glen Pietrandoni | |||
Marcelo Kugelmas | |||
Idania Lio | |||
Susan Simon | |||
P2860 | cites work | Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma | Q22305316 |
Price and affordability of direct-acting antiviral regimens for hepatitis C virus in the United States | Q26749246 | ||
Global epidemiology and genotype distribution of the hepatitis C virus infection | Q27001240 | ||
Barriers to hepatitis C treatment | Q27012664 | ||
Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention | Q28286743 | ||
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
Outcome of sustained virological responders with histologically advanced chronic hepatitis C. | Q34101701 | ||
Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. | Q34294185 | ||
A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C. | Q35131882 | ||
Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008 | Q36100389 | ||
Strategies for Expanding Access to HBV and HCV Testing and Care in the United States: The CDC Hepatitis Testing and Linkage to Care Initiative, 2012-2014 | Q36858828 | ||
Results of Hepatitis C Birth-Cohort Testing and Linkage to Care in Selected U.S. Sites, 2012-2014. | Q36858838 | ||
Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection | Q42989510 | ||
Testing for HCV infection: an update of guidance for clinicians and laboratorians | Q42991914 | ||
Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis | Q42995849 | ||
Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. | Q53118691 | ||
P433 | issue | 2 | |
P304 | page(s) | 98-104 | |
P577 | publication date | 2017-02-01 | |
P1433 | published in | Gastroenterology & hepatology | Q26842161 |
P1476 | title | Hepatitis C Point-of-Care Screening in Retail Pharmacies in the United States | |
P478 | volume | 13 |
Q61448697 | Hepatitis C elimination: challenges with under-diagnosis and under-treatment |
Q92559755 | High prevalence of hepatitis C virus infection and low level of awareness among people who recently started injecting drugs in a cross-sectional study in Germany, 2011-2014: missed opportunities for hepatitis C testing |
Q89789952 | Pharmacy-Based Infectious Diseases Management Programs Incorporating CLIA-Waived Point-of-Care Tests |
Search more.